2020
DOI: 10.1021/acs.biochem.9b01105
|View full text |Cite
|
Sign up to set email alerts
|

Tafenoquine: A Step toward Malaria Elimination

Abstract: There is a pressing need for compounds with broad-spectrum activity against malaria parasites at various life cycle stages to achieve malaria elimination. However, this goal cannot be accomplished without targeting the tenacious dormant liver-stage hypnozoite that causes multiple relapses after the first episode of illness. In the search for the magic bullet to radically cure Plasmodium vivax malaria, tafenoquine outperformed other candidate drugs and was approved by the U.S. Food and Drug Administration in 20… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
19
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2
1
1

Relationship

3
6

Authors

Journals

citations
Cited by 34 publications
(19 citation statements)
references
References 117 publications
0
19
0
Order By: Relevance
“…Additionally, while sexual P. falciparum gametocytes can be produced in culture, low differentiation rates limit the amount of protein that can be obtained [7,90] . Perhaps the most challenging stage in the parasite's life cycle to interrogate with proteomics is the dormant P. vivax liver stage, termed hypnozoites, that causes relapsing malaria [91] . Despite these constraints, generating sufficient material for chemoproteomic studies may still be viable by establishing methods that enrich the specific life stages (gametocytes, liver‐stage schizonts, and liver‐stage hypnozoites) [90,92] .…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, while sexual P. falciparum gametocytes can be produced in culture, low differentiation rates limit the amount of protein that can be obtained [7,90] . Perhaps the most challenging stage in the parasite's life cycle to interrogate with proteomics is the dormant P. vivax liver stage, termed hypnozoites, that causes relapsing malaria [91] . Despite these constraints, generating sufficient material for chemoproteomic studies may still be viable by establishing methods that enrich the specific life stages (gametocytes, liver‐stage schizonts, and liver‐stage hypnozoites) [90,92] .…”
Section: Discussionmentioning
confidence: 99%
“…The major advantage of tafenoquine over primaquine is its considerably longer plasma elimination half-life (approximately 15 days) (12, 13) which allows for single dose (radical cure) or weekly administration for prophylaxis, thus reducing adherence issues commonly associated with primaquine dosing regimens (14). Although not currently approved for transmission blocking, the potential utility of tafenoquine for such is evident given its gametocytocidal activity in vitro (15) and transmission blocking activity in murine models (16). Like primaquine, tafenoquine can cause severe hemolytic anemia in G6PD-deficient individuals at currently recommended doses (17); however, as with primaquine, it is possible that a sufficient safety margin may be present for its therapeutic use in G6PD-deficient individuals (18).…”
Section: Introductionmentioning
confidence: 99%
“…Tafenoquine (TQ) is an antimalarial drug of the 8-aminoquinoline (8-AQ) class. 1 , 2 A single oral dose is more often than not effective for the radical cure of Plasmodium vivax malaria. TQ is thought to prevent malarial recurrence by killing a dormant plasmodial stage in the liver, for which I coined the term “hypnozoite” more than four decades ago.…”
Section: Introductionmentioning
confidence: 99%